Market Place
Sourcing Support
NPPA Requests Bayer Zydus Pharma To Extend Urografin Sales
05 Mar 2026 //
PHARMABIZ
Zydus Group Elevates Dr. Tushar Nahata To Vice President
04 Jan 2026 //
INDPHARMAPOST
Zydus Receives EIR For The Injectable Facility Located At Jarod
04 Dec 2025 //
INDPHARMAPOST
Zydus` SEZ II Ahmedabad Plant Passes USFDA Inspection Flawlessly
16 Aug 2025 //
INDPHARMAPOST
NPPA asks Bayer Zydus to sell Urografin for one more year
29 Mar 2025 //
PHARMABIZ
Zydus receives approval to conduct Phase II(b) trial for Usnoflast
20 Jan 2025 //
EXPRESSPHARMA
Shilpa Medicare’s JV Oncosol gets USFDA approval for IMKELDI
28 Nov 2024 //
INDPHARMAPOST
Zydus Wellness Expands Complan Into Adult Nutrition With VieMax
08 Oct 2024 //
EXPRESSPHARMA
Zydus starts trial to generate data on effect of Saroglitazar in NAFLD patients
09 Jun 2023 //
ECONOMIC TIMES
Zydus launches Topiramate Extended-Release Capsules for epilepsy
06 Jan 2023 //
ECONOMICTIMES
US FDA grants tentative approval to Zydus’s Amantadine extended-release capsules
10 Oct 2022 //
EXPRESS PHARMA
BridgeBio Pharma and Sentynl Receive Marketing Authorization NULIBRY®
20 Sep 2022 //
GLOBENEWSWIRE
Zydus receives USFDA tentative approval for Sugammadex Injection
16 Sep 2022 //
BUSINESS-STANDARD
Zydus gets tentative approval from USFDA for Sugammadex Injection
16 Sep 2022 //
ECONOMICTIMES
Zydus receives final approval from US FDA for Ivermectin cream
05 Aug 2022 //
EXPRESS PHARMA
Zydus gets final US FDA approval for Empagliflozin tablets
04 Aug 2022 //
EXPRESS PHARMA
Zydus gets USFDA nod for Ivermectin cream
03 Aug 2022 //
ECONOMIC TIMES
Zydus receives final approval from USFDA for type 2 diabetes tablets
03 Aug 2022 //
ECONOMIC TIMES
Zydus Lifesciences gets USFDA nod to market generic high blood pressure drug
26 Jul 2022 //
ET HEALTH
Zydus gets USFDA nod to market generic antifungal medication
19 Jul 2022 //
ECONOMIC TIMES
Zydus receives final FDA approval for type 2 diabetes drug
11 Jul 2022 //
ET HEALTH
USFDA grants final approval for Zydus` seizure injections
30 Jun 2022 //
ET HEALTH
Zydus Pharmaceuticals (USA) Inc. joins the End Drug Shortages Alliance
29 Jun 2022 //
PRNEWSWIRE
Zydus Blasts Takeda`s Patent Abuse `Blueprint` At 3rd Circ.
15 Jun 2022 //
LAW360
Zydus receives final approval from FDA for Adapalene and Benzoyl Peroxide Gel
08 Jun 2022 //
EXPRESS PHARMA
Zydus Pivots To Multivariant COVID-19 Vaccine, Looks To Revlimid Opportunity
25 May 2022 //
THE SCRIP
Zydus to supply product to US firm Sagent from Gujarat plant
13 Apr 2022 //
ET HEALTH
Fresenius Sues Zydus Over Patents for Rare Thyroid Disease Drug
30 Mar 2022 //
BLOOMBERGLAW
Zydus Pharmaceuticals (USA) gets final FDA approval to market Roflumilast
14 Feb 2022 //
ECONOMIC TIMES
Cadila Healthcare`s US arm receives FDA nod to market Pimavanserin capsule
01 Jan 2022 //
ECONOMICTIMES
Zydus Cadila receives US FDA approval to market nelarabine injection
18 Nov 2021 //
PHARMABIZ
Zydus Cadila gets US FDA marketing approval for apremilast tablets
24 Sep 2021 //
PHARMABIZ
Amgen scores Otezla patent win, nabbing protection until 2028
22 Sep 2021 //
FIERCEPHARMA
EMA Orphan Drug Designation to Saroglitazar Mg for treating patients with PBC
21 Jul 2021 //
EXPRESS PHARMA
Row over Zydus vaccine trials as Noida seals illegal lab
17 Feb 2021 //
ECONOMICTIMES
FOGSI and Bayer Zydus Pharma collaborate to drive adoption of technology
30 Sep 2020 //
PHARMABIZ
India approves human trials for second COVID-19 vaccine candidate
02 Jul 2020 //
REUTERS
Wipro founder Azim Premji is an early investor in US firm Moderna
20 May 2020 //
ECONOMICTIMES
Zydus Cadila launches insomnia drug in US market
25 Jul 2019 //
ECONOMIC TIMES
Zydus Pharmaceuticals Inc among cos facing lawsuit by US states: Cadila
14 May 2019 //
ECONOMICTIMES
BioSpace Movers and Shakers: Feb. 8
08 Feb 2019 //
BIOSPACE
Zydus Cadila gets USFDA nod for antipsychotic drug
09 Jan 2019 //
ECONOMIC TIMES
Indian pharma companies grab 290 final ANDA approvals from US FDA in 2018
08 Jan 2019 //
PHARMABIZ
Zydus Cadila gets USFDA nod for leukemia treatment injection
13 Nov 2018 //
ECONOMIC TIMES
Zydus, Cadila To Buy Kraft Heinz’s India Portfolio
24 Oct 2018 //
BLOOMBERG
Zydus Cadila gets USFDA nod to market generic seizures treatment drug
23 Oct 2018 //
HINDU BUSINESS LINE
Zydus Cadila gets tentative USFDA nod for diabetes drug
11 Oct 2018 //
MONEY CONTROL
Zydus Cadila gets tentative USFDA nod for diabetes drug
11 Oct 2018 //
MONEY CONTROL
Zydus Cadila gets tentative USFDA nod for diabetes drug
11 Oct 2018 //
MONEY CONTROL
Zydus Cadila gets USFDA nod for breast cancer drug
05 Oct 2018 //
ECONOMIC TIMES
Nautic Partners Announces Acquisition of Mikart, Inc.; Michael Kallelis as CEO
27 Sep 2018 //
BUSINESSWIRE
Zydus Cadila gets FDA nod for osteoarthritis & RA drug
20 Jul 2018 //
ECONOMIC TIMES
Zydus Pharmaceuticals gets USFDA nod for OCD treatment drug
28 Dec 2017 //
ECONOMIC TIMES
Cadila gets USFDA nod for generic drug to treat Parkinson`s
14 Dec 2017 //
ECONOMIC TIMES
Cadila Healthcare’s arm receives final approval from USFDA for Clozapine Tablets
08 Dec 2017 //
BIOSPECTRUM
Zydus Announces Regulatory Approval of Lipaglyn™ Saroglitazar Magnesium
10 Nov 2017 //
PR NEWSWIRE
Zydus gets USFDA nod for anti-inflammatory drug
26 Sep 2017 //
MONEYCONTROL
Zydus receives US FDA marketing nod for amlodipine & olmesartan medoxomil tablet
25 Sep 2017 //
PHARMABIZ
Zydus & Pharm Aid enter into exclusive agreement for vaccine technology Russia
20 Sep 2017 //
ECONOMIC TIMES
Zydus gets US FDA tentative marketing nod for abacavir & lamivudine tablets
08 Aug 2017 //
PHARMABIZ
